Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis
- DOI
- 10.3390/biomedicines14051043
- Published
- 2026-05-03
- Container
- Biomedicines
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines14051043,
title = {Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis},
author = {Xavier Adhoute and Constance Chailloux and Feng Xia and Zhao Huang and Qian Chen and Jing Yan and Qiao Zhang and Victoria Ramdour and Louis Carmarans and Guillaume Pénaranda and Paul Castellani and Albert Tran and Marc Bourlière and René Gerolami and Rodolphe Anty},
year = {2026},
journal = {Biomedicines},
doi = {10.3390/biomedicines14051043},
url = {https://doi.org/10.3390/biomedicines14051043}
}RIS
TY - JOUR TI - Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis AU - Xavier Adhoute AU - Constance Chailloux AU - Feng Xia AU - Zhao Huang AU - Qian Chen AU - Jing Yan AU - Qiao Zhang AU - Victoria Ramdour AU - Louis Carmarans AU - Guillaume Pénaranda AU - Paul Castellani AU - Albert Tran AU - Marc Bourlière AU - René Gerolami AU - Rodolphe Anty PY - 2026 JO - Biomedicines DO - 10.3390/biomedicines14051043 UR - https://doi.org/10.3390/biomedicines14051043 ER -
APA
Adhoute, X., Chailloux, C., Xia, F., Huang, Z., Chen, Q., Yan, J., Zhang, Q., Ramdour, V., Carmarans, L., Pénaranda, G., Castellani, P., Tran, A., Bourlière, M., Gerolami, R., & Anty, R. (2026). Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis. Biomedicines. https://doi.org/10.3390/biomedicines14051043
Source records
- crossref · retrieved 2026-09-26T16:19:38.701Z